NATIONAL HEALTH INVESTORS INC

For the period ended Sep 30, 2026. Filed Nov 9, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Nov 9, 2026

NHI$67.79-4.8%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Equity

Capital in
Common Stock · Excess of · Retained · Cumulative · Noncontrolling · Total
	Shares	Amounts	Par Value	Earnings	Dividends	Interests	Equity
Balances at June 30, 2026	49,115,748	$491	$1,966,642	$2,842,779	$(3,238,486)	$7,464	$1,578,890
Net income, excluding a net loss of $210 attributable
to redeemable noncontrolling interest	—	—	—	563,525	—	(101)	563,424
Share-based compensation expense	—	—	1,463	—	—	—	1,463
Grants of restricted stock awards	2,370	—	—	—	—	—	—
Forfeitures of restricted stock awards	(4,227)	—	—	—	—	—	—
Cash settlement of restricted stock awards	(845)	—	(45)	—	—	—	(45)
Taxes paid related to net settlement of stock incentive awards	(2,612)	—	(230)	—	—	—	(230)
attributable to redeemable noncontrolling interest	—	—	—	—	—	(278)	(278)
Dividends declared, $0.94 per share	—	—	—	—	(46,183)	—	(46,183)
Balances at September 30, 2026	49,110,434	$491	$1,967,830	$3,406,304	$(3,284,669)	$7,085	$2,097,041

Capital in
Common Stock · Excess of · Retained · Cumulative · Noncontrolling · Total
Shares · Amounts · Par Value · Earnings · Dividends · Interests · Equity
Balances at June 30, 2025	47,473,160		$475		$1,863,582		$2,675,981		$(3,060,393)		$8,328		$1,487,973
Net income, excluding a net loss of $287 attributable to redeemable noncontrolling interest
—		—		—		32,862		—		(97)		32,765
Issuance of common shares, net	154,673		1		11,438		—		—		—		11,439
Share-based compensation expense	—		—		983		—		—		—		983
Shares issued due to stock options exercised	10,669		—		—		—		—		—		—
Taxes paid related to net settlement of stock incentive awards	—		—		(224)		—		—		—		(224)
Noncontrolling interest capital contribution	—		—		—		—		—		250		250
Distributions declared to non-controlling interests	—		—		—		—		—		(193)		(193)
Reversal of previously declared distributions
to non-controlling interest upon liquidation	—		—		—		—		—		298		298
Purchases of shares from noncontrolling interests	—		—		21		—		—		(21)		—
Dividends declared, $0.92 per share	—		—		—		—		(43,827)		—		(43,827)
Balances at September 30, 2025	47,638,502		$476		$1,875,800		$2,708,843		$(3,104,220)		$8,565		$1,489,464

Capital in
Common Stock · Excess of · Retained · Cumulative · Noncontrolling · Total
	Shares	Amounts	Par Value	Earnings	Dividends	Interests	Equity
Balances at December 31, 2025	48,302,944	$483	$1,922,713	$2,747,006	$(3,148,659)	$8,166	$1,529,709
Net income, excluding a net loss of $684 attributable
to redeemable noncontrolling interest	—	—	—	659,298	—	(291)	659,007
Issuance of common shares, net	642,610	6	44,928	—	—	—	44,934
Equity issuance costs	—	—	(414)	—	—	—	(414)
Share-based compensation expense	—	—	6,063	—	—	—	6,063
Grants of restricted stock awards	45,415	—	—	—	—	—	—
Forfeitures of restricted stock awards	(4,227)	—	—	—	—	—	—
Cash settlement of restricted stock awards	(845)	—	(45)	—	—	—	(45)
Shares issued due to stock options exercised	130,087	2	—	—	—	—	2
Taxes paid related to net settlement of stock incentive awards	(5,550)	—	(5,415)	—	—	—	(5,415)
attributable to redeemable noncontrolling interest	—	—	—	—	—	(790)	(790)
Dividends declared, $2.78 per share	—	—	—	—	(136,010)	—	(136,010)
Balances at September 30, 2026	49,110,434	$491	$1,967,830	$3,406,304	$(3,284,669)	$7,085	$2,097,041

Capital in
Common Stock · Excess of · Retained · Cumulative · Noncontrolling · Total
	Shares	Amounts	Par Value	Earnings	Dividends	Interests	Equity
Balances at December 31, 2024	45,687,942	$457	$1,736,831	$2,604,829	$(2,975,642)	$8,912	$1,375,387
Net income, excluding a net loss of $723 attributable
to redeemable noncontrolling interest	—	—	—	104,014	—	(307)	103,707
Issuance of common shares, net	1,891,021	19	134,904	—	—	—	134,923
Equity issuance costs	—	—	(153)	—	—	—	(153)
Share-based compensation expense	—	—	4,612	—	—	—	4,612
Grants of restricted stock awards	29,500	—	—	—	—	—	—
Shares issued due to stock options exercised	31,226	—	—	—	—	—	—
Taxes paid related to net settlement of stock incentive awards	(1,187)	—	(415)	—	—	—	(415)
Noncontrolling interest capital contributions	—	—	—	—	—	306	306
attributable to redeemable noncontrolling interest	—	—	—	—	—	(623)	(623)
Reversal of previously declared distributions
to noncontrolling interests upon liquidation	—	—	—	—	—	298	298
Purchases of shares from noncontrolling interests	—	—	21	—	—	(21)	—
Dividends declared, $2.72 per share	—	—	—	—	(128,578)	—	(128,578)
Balances at September 30, 2025	47,638,502	$476	$1,875,800	$2,708,843	$(3,104,220)	$8,565	$1,489,464

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.